Mergers & Acquisitions

A 48-hour wave of cross-border deals — including KKR’s $11.3B acquisition of EDF’s North American assets and Elroy Air’s $1B SPAC listing — signals a structural shift in how private equity and venture capital are deploying capital globally. M&A Directors and CFOs must adapt due diligence and post-merger integration frameworks to match the accelerating pace of regulatory approvals in the EU and U.S.

Private equity firms and corporate acquirers are driving a surge in cross-border M&A, with multibillion-dollar deals reshaping global corporate finance. CFOs and M&A directors must prioritise due diligence rigour and post-merger integration planning to compete effectively in this environment.

A cluster of landmark cross-border transactions in 2025 — from GameGame’s $56B eBay bid to Merck KGaA’s $11.3B Bio-Techne acquisition — is redefining corporate finance strategy across digital, energy, and life sciences sectors. CFOs and M&A Directors must prioritise multi-jurisdictional regulatory mapping and post-merger integration governance from the earliest stages of deal execution.

From Merck KGaA’s $11.3 billion acquisition of Bio-Techne to Safran’s move into autonomous maritime defense, cross-border M&A in 2025 is accelerating across energy, life sciences, and deep tech. LLS examines the structural forces driving deal activity and the due diligence imperatives for executive decision-makers.

Merck KGaA’s $11.3B acquisition of Bio-Techne and ON Semiconductor’s $7B Synaptics deal signal a structural shift in cross-border M&A toward life sciences and AI hardware. European CFOs and M&A Directors must act now as regulatory complexity and mid-market re-rating accelerate.

Merck KGaA’s $11.3 billion acquisition of Bio-Techne marks the largest cross-border life sciences deal of the quarter, setting a new benchmark for due diligence rigour and post-merger integration strategy. M&A directors and CFOs should treat this transaction as a strategic reference point for cross-Atlantic deal-making in 2025.

Five landmark cross-border transactions in 2025 — from Compass’s $1.3B real estate acquisition to the EU’s probe into JD.com’s €2.2B Ceconomy bid — are redefining M&A strategy across sectors. Senior executives must now treat regulatory risk, private equity dynamics, and post-merger integration as core deal variables, not peripheral concerns.

KKR’s revised $615 billion bid for Tatts Group and a wave of cross-border transactions signal a new phase of global M&A intensity, with regulatory scrutiny and post-merger integration emerging as the decisive variables. Decision-makers in Europe and beyond must recalibrate their deal frameworks accordingly.

From Compass’s landmark acquisition of Anywhere Real Estate to SMBC’s $1.6 billion cross-border entry into India’s banking sector, 2025 is delivering a decisive acceleration in global M&A activity. CFOs, General Counsel, and M&A Directors must act on the structural lessons these deals provide around due diligence, regulatory navigation, and post-merger integration.

The $130 billion DuPont-Dow all-stock merger — structured from inception to split into three independent companies — sets a new benchmark for post-merger architecture and cross-border deal strategy. For CFOs and M&A directors, the real lesson lies not in the deal’s scale, but in its design logic.